O W Sacks, M Kohl, W Schwartz, C Messeloff. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Dihydroxyphenylalanine/adverse effectsHumansParkinson Disease/drug therapyParkinson Disease/etiology
Substances: See more » Dihydroxyphenylalanine
Year: 1970 PMID: 4191927 DOI: 10.1016/s0140-6736(70)91137-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321